Quick Answer
Wave Life Sciences Ltd. reported Cash And Cash Equivalents At Carrying Value of $602.07 million for the year ending 2025.
- Wave Life Sciences Ltd. showed an increase of +99.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $2.49 million | Q1 2015: $10.96 million | Q2 2015: $7.78 million | Q3 2015: $66.04 million | Q1 2016: $153.40 million | Q2 2016: $181.77 million | Q3 2016: $169.02 million | Q1 2017: $129.48 million | Q2 2017: $197.39 million | Q3 2017: $168.46 million | Q1 2018: $110.49 million | Q2 2018: $241.43 million | Q3 2018: $210.49 million | Q1 2019: $287.57 million | Q2 2019: $252.91 million | Q3 2019: $209.01 million | Q1 2020: $120.95 million | Q2 2020: $216.40 million | Q3 2020: $216.36 million | Q1 2021: $148.54 million | Q2 2021: $143.84 million | Q3 2021: $123.90 million | Q1 2022: $61.71 million | Q2 2022: $123.16 million | Q3 2022: $96.95 million | Q1 2023: $207.56 million | Q2 2023: $172.97 million | Q3 2023: $139.94 million | Q1 2024: $180.92 million | Q2 2024: $153.96 million | Q3 2024: $310.95 million | Q1 2025: $243.08 million | Q2 2025: $208.48 million | Q3 2025: $196.22 million.
- Over the full 14 years of available data (2012 to 2025), Wave Life Sciences Ltd.'s Cash And Cash Equivalents At Carrying Value has grown by 158,757.0%.
- Historical annual values: Fiscal year 2025: $602.07 million | Fiscal year 2024: $302.08 million | Fiscal year 2023: $200.35 million | Fiscal year 2022: $88.50 million | Fiscal year 2021: $150.56 million | Fiscal year 2020: $184.50 million | Fiscal year 2019: $147.16 million | Fiscal year 2018: $174.82 million | Fiscal year 2017: $142.50 million | Fiscal year 2016: $150.29 million | Fiscal year 2015: $161.22 million | Fiscal year 2014: $1.05 million | Fiscal year 2013: $439.0 thousand | Fiscal year 2012: $379.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: